Gene, stem cell therapies may have far-reaching implications for coronary artery grafts

Researchers are exploring the potential for gene and stem cell therapy in coronary artery bypass grafts to prevent re-occlusion in the grafted vein. Based on animal studies, the team is seeing a marked improvement in preventing re-occlusion, with no side effects.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1cQ0jHM